RELMADA THERAPEUTICS INC's ticker is RLMD and the CUSIP is 75955J402. A total of 98 filers reported holding RELMADA THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.42 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,930,105 | +22.0% | 1,310,035 | 0.0% | 0.00% | – |
Q2 2023 | $3,222,686 | -5.3% | 1,310,035 | -13.0% | 0.00% | – |
Q1 2023 | $3,401,253 | -35.8% | 1,504,979 | -0.8% | 0.00% | – |
Q4 2022 | $5,294,260 | -90.1% | 1,516,980 | +5.1% | 0.00% | -100.0% |
Q3 2022 | $53,456,000 | +97.8% | 1,443,960 | +1.5% | 0.00% | +100.0% |
Q2 2022 | $27,023,000 | -24.4% | 1,423,032 | +7.5% | 0.00% | 0.0% |
Q1 2022 | $35,736,000 | +29.5% | 1,324,014 | +8.1% | 0.00% | 0.0% |
Q4 2021 | $27,598,000 | +15.1% | 1,224,901 | +33.9% | 0.00% | 0.0% |
Q3 2021 | $23,975,000 | -3.0% | 914,723 | +18.5% | 0.00% | 0.0% |
Q2 2021 | $24,705,000 | +1.2% | 771,776 | +11.3% | 0.00% | 0.0% |
Q1 2021 | $24,411,000 | +14.9% | 693,307 | +4.6% | 0.00% | 0.0% |
Q4 2020 | $21,250,000 | -16.0% | 662,623 | -1.5% | 0.00% | 0.0% |
Q3 2020 | $25,311,000 | -18.2% | 672,781 | -2.7% | 0.00% | 0.0% |
Q2 2020 | $30,951,000 | +56.5% | 691,652 | +19.3% | 0.00% | 0.0% |
Q1 2020 | $19,779,000 | -11.0% | 579,858 | +1.8% | 0.00% | 0.0% |
Q4 2019 | $22,220,000 | – | 569,753 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
VR Adviser, LLC | 668,440 | $25,147,000 | 4.92% |
TANG CAPITAL MANAGEMENT LLC | 500,000 | $18,810,000 | 3.40% |
ACUTA CAPITAL PARTNERS, LLC | 277,000 | $10,421,000 | 2.83% |
PARSONS CAPITAL MANAGEMENT INC/RI | 455,137 | $17,122,000 | 1.67% |
RTW INVESTMENTS, LP | 1,511,337 | $56,857,000 | 1.37% |
Avoro Capital Advisors LLC | 1,500,000 | $56,430,000 | 0.80% |
Pegasus Asset Management, Inc. | 26,958 | $1,014,000 | 0.64% |
RA Capital Management | 781,290 | $29,392,000 | 0.54% |
TIEDEMANN ADVISORS, LLC | 269,839 | $10,151,000 | 0.49% |
Boxer Capital, LLC | 300,000 | $11,286,000 | 0.39% |